Literature DB >> 18378950

The case for treating tobacco dependence as a chronic disease.

Michael B Steinberg1, Amy C Schmelzer, Donna L Richardson, Jonathan Foulds.   

Abstract

Smoking remains the leading cause of preventable death in the United States, yet it is still regarded by many as merely a bad habit. Most smokers want to quit but find it difficult. Behavioral counseling and pharmacotherapies are available, safe, and effective in the treatment of tobacco dependence. Nicotine replacement therapy effectively delivers nicotine in safer doses without exposure to the toxins and chemicals in cigarette smoke. The optimal duration of tobacco dependence treatment is unknown, and some smokers may require extended courses. For smokers using long-term cessation medications, health care providers should encourage treatment and insurance carriers should cover it. Both tobacco dependence and such conditions as diabetes are similar in their potential to exacerbate other diseases, their behavioral components of treatment, and their effectiveness of medications. Despite these similarities, treatments for diabetes are well covered by insurance, whereas tobacco dependence treatments are often limited. Tobacco dependence should share the status of other chronic illnesses, with effective treatments given as long as is necessary to achieve successful clinical outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18378950     DOI: 10.7326/0003-4819-148-7-200804010-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  22 in total

Review 1.  Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Authors:  Raymond Niaura; Geetanjali Chander; Heidi Hutton; Cassandra Stanton
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

2.  Parent eReferral to Tobacco Quitline: A Pragmatic Randomized Trial in Pediatric Primary Care.

Authors:  Brian P Jenssen; Naveen Muthu; Mary Kate Kelly; Hilary Baca; Justine Shults; Robert W Grundmeier; Alexander G Fiks
Journal:  Am J Prev Med       Date:  2019-05-21       Impact factor: 5.043

Review 3.  Do brief alcohol interventions reduce tobacco use among adolescents and young adults? A systematic review and meta-analysis.

Authors:  Emily A Hennessy; Emily E Tanner-Smith; Katarzyna T Steinka-Fry
Journal:  J Behav Med       Date:  2015-07-01

4.  Recruiting and engaging smokers in treatment in a primary care setting: developing a chronic care model implemented through a modified electronic health record.

Authors:  Megan E Piper; Timothy B Baker; Robin Mermelstein; Linda M Collins; David L Fraser; Douglas E Jorenby; Stevens S Smith; Bruce A Christiansen; Tanya R Schlam; Jessica W Cook; Madeline Oguss; Michael C Fiore
Journal:  Transl Behav Med       Date:  2013-09       Impact factor: 3.046

5.  Strategies to help a smoker who is struggling to quit.

Authors:  Nancy A Rigotti
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

Review 6.  Treating tobacco dependence in light of the 2008 US Department of Health and Human Services clinical practice guideline.

Authors:  J Taylor Hays; Jon O Ebbert; Amit Sood
Journal:  Mayo Clin Proc       Date:  2009-08       Impact factor: 7.616

7.  Smoking cessation is challenging even for patients recovering from lung cancer surgery with curative intent.

Authors:  Mary E Cooley; Linda Sarna; Jenny Kotlerman; Jeanne M Lukanich; Michael Jaklitsch; Sarah B Green; Raphael Bueno
Journal:  Lung Cancer       Date:  2009-03-24       Impact factor: 5.705

8.  Undertreatment of tobacco use relative to other chronic conditions.

Authors:  Steven L Bernstein; Sunkyung Yu; Lori A Post; James Dziura; Nancy A Rigotti
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

9.  Implementation of the Tobacco Tactics program in the Department of Veterans Affairs.

Authors:  Sonia A Duffy; Carrie A Karvonen-Gutierrez; Lee A Ewing; Patricia M Smith
Journal:  J Gen Intern Med       Date:  2010-01       Impact factor: 5.128

Review 10.  Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.

Authors:  Jon O Ebbert; Kirk D Wyatt; Ali Zirakzadeh; Michael V Burke; Jt Hays
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.